MENU
+Compare
XOMA
Stock ticker: NASDAQ
AS OF
Sep 26, 12:45 PM (EDT)
Price
$36.19
Change
+$0.48 (+1.34%)
Capitalization
431.65M

XOMA XOMA Royalty Corporation Forecast, Technical & Fundamental Analysis

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more

Industry: #Biotechnology
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XOMA with price predictions
Sep 24, 2025

Aroon Indicator for XOMA shows an upward move is likely

XOMA's Aroon Indicator triggered a bullish signal on September 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 196 similar instances where the Aroon Indicator showed a similar pattern. In of the 196 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOMA advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XOMA moved out of overbought territory on September 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where XOMA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XOMA turned negative on September 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOMA broke above its upper Bollinger Band on September 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.671) is normal, around the industry mean (19.844). P/E Ratio (0.000) is within average values for comparable stocks, (54.097). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.112). Dividend Yield (0.020) settles around the average of (0.044) among similar stocks. P/S Ratio (33.445) is also within normal values, averaging (344.917).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

XOMA is expected to report earnings to fall 119.32% to -8 cents per share on November 06

XOMA Royalty Corporation XOMA Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Beat
by $0.64
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
The last earnings report on August 13 showed earnings per share of 43 cents, beating the estimate of -20 cents. With 2.03K shares outstanding, the current market capitalization sits at 431.65M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Powell Street
Phone
+1 510 204-7200
Employees
13
Web
https://www.xoma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIWEX17.890.10
+0.56%
Cavanal Hill World Energy Institutional
FBTIX34.77N/A
N/A
Fidelity Advisor Biotechnology I
OLVTX21.45N/A
N/A
JPMorgan Large Cap Value R3
LYRNX14.50N/A
N/A
Lyrical International Value Equity Inv
MSOAX38.25-0.43
-1.11%
NYLI WMC Enduring Capital Class A

XOMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
-2.56%
SYRE - XOMA
40%
Loosely correlated
-8.18%
OLMA - XOMA
39%
Loosely correlated
-1.98%
FHTX - XOMA
38%
Loosely correlated
-4.28%
ARWR - XOMA
38%
Loosely correlated
-3.56%
RVMD - XOMA
38%
Loosely correlated
-2.41%
More